Marker Therapeutics, Inc. (MRKR)

2.04 -0.15 (-6.85%) USD  |  NASDAQ  |  Jan 22, 16:00
2.03 -0.01 (-0.49%) After-Hours: 06:07
More

Marker Therapeutics Properties (Per Share)

Properties (Per Share) Chart

View Properties (Per Share) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Properties (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Properties (Per Share) Range, Past 5 Years

View Properties (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Properties (Per Share) Benchmarks

View Properties (Per Share) Benchmarks
Start Trial
Viridian Therapeutics, Inc. --
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. --
AIM ImmunoTech, Inc. --